In Memoriam: Philip Neil Sambrook T. V. NguyenJ. A. EismanM. J. Seibel Obituary 10 May 2012 Pages: 1835 - 1836
Frailty and sarcopenia: definitions and outcome parameters C. CooperW. DereJ.-Y. L. Reginster Review 31 January 2012 Pages: 1839 - 1848
SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions J. C. DavisT. Liu-AmbroseC. A. Marra Original Article 10 September 2011 Pages: 1849 - 1857
Mortality after vertebral fracture in Korea Y.-K. LeeS. JangD.-Y. Kim Original Article 23 November 2011 Pages: 1859 - 1865
A follow-up association study of two genetic variants for bone mineral density variation in Caucasians L.-S. ZhangH.-G. HuH.-W. Deng Original Article 09 December 2011 Pages: 1867 - 1875
Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk S.-M. XiaoY. GaoA. W. C. Kung Original Article Open access 04 January 2012 Pages: 1877 - 1887
Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families W.-J. XiaoY.-H. KeZ.-L. Zhang Original Article 17 November 2011 Pages: 1889 - 1897
A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma S. ErmakovS. TrofimovG. Livshits Original Article 05 November 2011 Pages: 1899 - 1907
Hydrolyzed collagen improves bone status and prevents bone loss in ovariectomized C3H/HeN mice F. GuillerminetV. Fabien-SouléA. Blais Original Article 17 September 2011 Pages: 1909 - 1919
Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors M. J. KangS. M. KimJ. S. Lim Original Article 05 November 2011 Pages: 1921 - 1929
A clinical decision rule to enhance targeted bone mineral density testing in healthy mid-life women G. HawkerA. MendelS. Jaglal Original Article 10 December 2011 Pages: 1931 - 1938
Lactation is associated with greater maternal bone size and bone strength later in life P. K. WiklundL. XuS. Cheng Original Article 17 September 2011 Pages: 1939 - 1945
Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men J. RawalK. EleftheriouH. Montgomery Original Article 06 January 2012 Pages: 1947 - 1956
Vertebral body bone strength: the contribution of individual trabecular element morphology I. H. ParkinsonA. BadieiN. L. Fazzalari Original Article 16 November 2011 Pages: 1957 - 1965
Comparative high-resolution pQCT analysis of femoral neck indicates different bone mass distribution in osteoporosis and osteoarthritis A. RubinacciD. TresoldiG. Rizzo Original Article 24 September 2011 Pages: 1967 - 1975
Assessment of technical and biological parameters of volumetric quantitative computed tomography of the foot: a phantom study K. E. SmithB. R. WhitingF. W. Prior Original Article 07 December 2011 Pages: 1977 - 1985
Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders A. MussaF. PortaA. Corrias Original Article 23 September 2011 Pages: 1987 - 1998
Anatomical distribution of vertebral fractures: comparison of pediatric and adult spines K. SiminoskiK.-C. LeeSTOPP Consortium Original Article 23 November 2011 Pages: 1999 - 2008
Fat mass is negatively associated with bone mineral content in Koreans J. H. KimH. J. ChoiN. H. Cho Original Article 18 October 2011 Pages: 2009 - 2016
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages L. DesjardinsS. Liabeufon behalf of the European Uremic Toxin (EUTox) Work Group Original Article 23 November 2011 Pages: 2017 - 2025
Serum adiponectin and bone mineral density in male hemodialysis patients S. OkunoE. IshimuraM. Inaba Original Article 17 September 2011 Pages: 2027 - 2035
Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease F. S. NevesL. S. A. F. OliveiraI. Crusoé-Rebello Original Article 18 October 2011 Pages: 2037 - 2042
Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass P. HadjiV. ZillerP. H. Kann Original Article 16 November 2011 Pages: 2043 - 2051
Soluble fatty acid synthase relates to bone biomarkers in prepubertal children A. Prats-PuigT. PuigA. López-Bermejo Short Communication 30 August 2011 Pages: 2053 - 2058
Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis M. YilmazH. TaninmisA. Unsal Case Report 26 January 2012 Pages: 2059 - 2062
Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis B. JönssonO. StrömJ. A. Kanis Letter 16 November 2011 Pages: 2063 - 2065